Somatostatin and insulin mediate glucose-inhibited glucagon secretion in the pancreatic α-cell by lowering cAMP
Year: 2014
Type: article
Abstract: The dysregulation of glucose-inhibited glucagon secretion from the pancreatic islet α-cell is a critical component of diabetes pathology and metabolic disease. We show a previously uncharacterized [Ca(2+)]i-independent mechanism of glucagon suppression in human and murine pancreatic islets whereby cAMP and PKA signaling are decreased. This decrease is driven by the combination of somatostatin, which inhibits adenylyl cyclase production of cAMP via the Gαi subunit of the SSTR2, and insulin, which acts via its receptor to activate phosphodiesterase 3B and degrade cytosolic cAMP. Our data indicate that both somatostatin and insulin signaling are required to suppress cAMP/PKA and glucagon secretion from both human and murine α-cells, and the combination of these two signaling mechanisms is sufficient to reduce glucagon secretion from isolated α-cells as well as islets. Thus, we conclude that somatostatin and insulin together are critical paracrine mediators of glucose-inhibited glucagon secretion and function by lowering cAMP/PKA signaling with increasing glucose.
Institution: Vanderbilt University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G117257630, Molecular Biophysics Training Grant at Vanderbilt, Dopamine Action in Pancreatic Islet Function, Pancreatic Islets Dynamics Regulating Glucagon Secretion, Dynamics of Pancreatic Islet Function, Multiphoton microscope upgrade, Multi-Function Laser Scanning Microscope, Molecular and Cellular Basis for Digestive Diseases, Cancer Center Support Grant, Vanderbilt Diabetes Research Center
OpenAlex ID: W2021920528
